Orange Book product · Generic (ANDA)
FLUTICASONE PROPIONATE
FLUTICASONE PROPIONATE
At a glance
Jan 09, 2012
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 09, 2012
14 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
FLUTICASONE PROPIONATE
Strength
0.05MG/SPRAY
Dosage form
SPRAY, METERED
Route
NASAL
TE code
AB
Application
ANDA 078492
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of FLUTICASONE PROPIONATE
- 2022ARMONAIR DIGIHALERBrand (NDA)
NDA 208798 · TEVA PHARM
- 2017XHANCEBrand (NDA)
NDA 209022 · PARATEK PHARMS
- 2014FLONASE ALLERGY RELIEFBrand (NDA)
NDA 205434 · HALEON US HOLDINGS
- 2005CUTIVATEBrand (NDA)
NDA 021152 · FOUGERA PHARMS
- 2004FLOVENT HFABrand (NDA)
NDA 021433 · GLAXO GRP LTD
- 2000FLOVENT DISKUS 100Brand (NDA)
NDA 020833 · GLAXO GRP LTD
- 1997FLOVENTBrand (NDA)
NDA 020549 · GLAXOSMITHKLINE
- 1996FLOVENTBrand (NDA)
NDA 020548 · GLAXOSMITHKLINE
- 1994FLONASEBrand (NDA)
NDA 020121 · HALEON US HOLDINGS
- 1990CUTIVATEBrand (NDA)
NDA 019958 · FOUGERA PHARMS
- 1990CUTIVATEBrand (NDA)
NDA 019957 · FOUGERA PHARMS
- 2026FLUTICASONE PROPIONATEGeneric (ANDA)
ANDA 218742 · GLENMARK SPECLT
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
